")}("position","absolute",["\/lib\/bootstrap\/dist\/css\/bootstrap.min.css"],"rel=\u0022stylesheet\u0022 ");
Published On: Friday, June 11, 2021 | By: Team KnowMyStock
Downside risks, however, include a third wave, a slower pace of vaccination, capital outflows and higher commodity prices. Upside risks include a faster pace of vaccination.
“The bottoming of ultra-high frequency indicators at end-May and the measured reopening across states suggest the worst might be over, although growth is likely to rise only gradually in June,” Nomura said.
GDP, according to their estimates, is likely to contract by 4.3 per cent quarter-on-quarter (q-o-q) in Q2, much smaller than during the first wave (-24.7 per cent). Beyond Q2, tailwinds such as strong global growth, an increased pace of vaccination, easy financial conditions and front-loaded fiscal activism should help GDP growth reach 9.8 per cent in 2021 and 7.7 per cent in 2022, Nomura said, and expects 50 per cent of the Indian population to be inoculated by end-2021. This, however, is in stark contrast to those at Jefferies, who expect just 32 per cent of Indian citizens to be fully vaccinated by the end of the year.
Meanwhile, Nomura sees policy normalisation to begin in Q4-2021, with liquidity normalisation and a 40 basis point (bp) hike in the reverse repo rate. "We now expect a cumulative 75bp of repo rate hikes in 2022, in light of higher inflationary pressures," they said.
Follow Us On: